ofloxacin, ciprofloxacin, cefotaxime, ceftazidime, ceftriaxone, and doxycycline and was resistant to amoxicillin, cephalothin, and trimethoprim-sulfamethoxazole (Table 1) .
After the treatment with ampicillin and gentamicin was changed to ceftriaxone treatment, the patient defervesced but remained icteric. The echocardiography was performed again and showed the presence of vegetation on the mitral prosthesis. The patient died 2 days later.
Discussion. C. luteola is a motile aerobic gram-negative rod with yellow-orange pigment. Yellow and smooth colonies are obtained after 48 h of incubation on heart infusion agar supplemented with 5% horse blood. C. luteola can be distinguished from most other motile yellow-pigmented nonfermenters by a negative oxidase reaction and from the enterobacteria by its strict aerobic growth (5) . The normal habitat of C. luteola is unclear, but it is frequently found in water, soil, and other damp environments (5, 16) . C. luteola was initially assigned to CDC group Ve-1 by Tatum et al. (as cited in references 7 and 14). Ve-1 is one of the biogroups of group Ve, a group of nonfermentative strains, named Chromobacterium typhiflavum by Pickett and Pedersen (13) . Strains of group Ve-1 were first classified as Pseudomonas luteola by Kodama et al. (9) . Holmes et al. (8) reclassified the species in the genus Chryseomonas as C. luteola, because P. luteola was a senior subjective synonym of Chryseomonas polytricha. Due to the close phylogenetic relatedness between Chryseomonas and Pseudomonas, this bacterium was reassigned to the genus Pseudomonas as Pseudomonas luteola (1) . Currently, some authors still call the organism Chryseomonas luteola while others refer to it as Pseudomonas luteola (1, 6, 11, 17) .
Previous studies showed that C. luteola may cause septicemia, peritonitis, and endocarditis in patients with health disorders or with indwelling devices (12) . Up to now, 14 cases of C. luteola infection have been reported (2, 3, 5, 15, 17) . For seven patients the organism was isolated from blood. Infections previously described include primarily septicemia (2), meningitis (10), osteomyelitis, endocarditis (12) , and peritonitis (3). Also, its ability to infect critically ill patients who have undergone surgical operations and/or had indwelling devices has been described (7) . In other cases, the infection was associated with other factors, such as immunosuppressive therapy, chronic renal failure, and malignancy (14) .
As far as we know, C. luteola infections in humans have never been reported in Morocco. In this work, we describe two cases in a Moroccan university hospital. The two cases reported had predisposing or associated factors: the first patient was a newborn in a transient immunosuppressive state, and the second had a mitral prosthesis.
Considering both cases, we noticed that the incubation period of the infection was different and varied from 1 day for the first case to 1 month for the second. In a previous report, a case of cerebral tumor was infected 3 1 / 2 months after a surgical operation (10) . Another case was reported as non-Hodgkin's lymphoma. The patient's subclavian Groshong catheter was flushed with sterile water, and the patient developed fever 1 h later (7). It seems the duration of the incubation period is unknown and may vary with the history of the infection.
It is reported that C. luteola is very resistant to trimethoprim-sulfamethoxazole, narrow-and expanded-spectrum cephalosporins, tetracycline, and ampicillin and susceptible to broad-spectrum antibiotics, such as cephalosporins, aminosids, and ciprofloxacin (4). Both isolates from the present study were susceptible to tetracycline. In the first case of the present study, the isolate was resistant to broad-spectrum cephalosporins and aminosids. For this reason the patient did not respond to treatment with ceftriaxone. With our second patient, the isolate was susceptible to ceftriaxone. However, C. luteola infections associated with foreign material are difficult to treat, and the prosthesis usually has to be removed (3, 10) . With our patient, this surgical operation was not done because the physicians failed to find cardiac vegetation in the first stage of the disease.
Since these two bacteria were isolated from the same hospital, we performed molecular typing using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The preliminary results showed significant differences between these strains and the reference strain. The two organisms isolated seemed not to be clonally related because of the differences noticed in their behavior against antibiotics, which means that the phenotypes of these isolates are different. Furthermore, the interval between the two infections was 24 months. Other molecular genotypic tools, like rep-PCR or pulsed-field gel electrophoresis, might be useful for confirmation.
Because of the dramatic outcome of both described human infections, addition of this bacterium to the expanding list of nosocomial pathogens (7) may warrant consideration. 
